Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05713552 · ClinicalTrials.gov registry record · NA
Evaluation of ACUVUE® OASYS 1-Day for Astigmatism Contact Lenses With Alternative Lidstock
A NA study, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT05713552 is a NA study that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 31 participants.
The verdict
NCT05713552, a NA study, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
This will be a single-visit, randomized, double-masked, bilateral wear, non-dispensing, 2-sequence × 2-period crossover study to evaluate subject reported ocular symptoms.
Interventions
- DEVICE Acuvue Oasys 1 Day for Astigmatism with Legacy lidstock
- DEVICE Acuvue Oasys 1 Day for Astigmatism with Amcor laminated lidstock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2023-01-30 |
| Est. Completion | 2023-02-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05713552
The ClinicalTrials.gov registry entry for NCT05713552 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Acuvue Oasys 1 Day for Astigmatism with Legacy lidstock is the first listed.
NCT05713552 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05713552 about?
NCT05713552 is a clinical study titled "Evaluation of ACUVUE® OASYS 1-Day for Astigmatism Contact Lenses With Alternative Lidstock". This will be a single-visit, randomized, double-masked, bilateral wear, non-dispensing, 2-sequence × 2-period crossover study to evaluate subject reported ocular symptoms.
What is the current status of trial NCT05713552?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2023-01-30. Estimated completion is 2023-02-09.
What interventions are being tested in trial NCT05713552?
The interventions under investigation include: Acuvue Oasys 1 Day for Astigmatism with Legacy lidstock (DEVICE), Acuvue Oasys 1 Day for Astigmatism with Amcor laminated lidstock (DEVICE).
Who is sponsoring clinical trial NCT05713552?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.